findmyKOL
Clinical trialNCT01447927CompletedPhase 2Interventional

Metformin Hydrochloride in Preventing Esophageal Cancer in Patients With Barrett Esophagus

SponsorNational Cancer Institute (NCI)Enrollment93Barrett EsophagusEsophageal Cancer
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Amitabh Chak

    Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Canada
  • University of Toronto

    Toronto, Ontario, Canada

Puerto Rico
  • University of Puerto Rico

    San Juan, Puerto Rico

United States
  • Hines Veterans Administration Hospital

    Hines, Illinois, United States

  • Mayo Clinic

    Rochester, Minnesota, United States

  • Case Comprehensive Cancer Center

    Cleveland, Ohio, United States

  • Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center

    Cleveland, Ohio, United States

  • University of Pittsburgh Medical Center - Shadyside Hospital

    Pittsburgh, Pennsylvania, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Jun 2012
Primary completion
31 May 2013
Completion
30 Sept 2013
Last update posted
21 Jul 2014
Registered enrollment
93
Registry id
NCT01447927

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.